Virtu Financial LLC Rhythm Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$21.39 - $49.64 $566,856 - $1.32 Million	26,501 New	26,501 $1.22 Million
Q2 2023 Jul 27, 2023	BUY	$16.32 - $21.15 $215,228 - $278,926	13,188 New	13,188 $217,000
Q2 2022 Aug 09, 2022	BUY	$3.12 - $12.25 $70,717 - $277,658	22,666 New	22,666 $94,000
Q2 2018 Jul 30, 2018	SELL	$17.02 - $35.2 $110,647 - $228,835	-6,501 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$17.02 - $35.2 $110,647 - $228,835	6,501 New	6,501 $203,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.